Response to Letter Regarding Article, "Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial"

被引：0
|
作者：
Shahbaznejad, Leila [1 ]
Davoudi, Alireza [2 ]
Eslami, Gohar [3 ]
Markowitz, John S. [4 ]
Navaeifar, Mohammad Reza [1 ]
Hosseinzadeh, Fatemeh [1 ]
Movahedi, Faeze Sadat [5 ]
Rezai, Mohammad Sadegh [1 ]
机构：
[1] Mazandaran Univ Med Sci, Communicable Dis Inst, Pediat Infect Dis Res Ctr, Sari, Iran
[2] Mazandaran Univ Med Sci, Communicable Dis Inst, Dept Infect Dis, Antimicrobial Resistance Res Ctr, Sari, Iran
[3] Mazandaran Univ Med Sci, Cardiovasc Res Ctr, Fac Pharm, Dept Clin Pharm, Sari, Iran
[4] Univ Florida, Ctr Pharmacogen & Precis Med, Dept Pharmacotherapy & Translat Res, Gainesville, FL USA
[5] Mazandaran Univ Med Sci, Student Res Comm, Sari, Iran
来源：
CLINICAL THERAPEUTICS | 2021年 / 43卷 / 09期
关键词：
D O I：
10.1016/j.clinthera.2021.07.006
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1624 / 1626
页数：3
相关论文
共 50 条
  • [31] Response to letter to the editor: The effects of amantadine on traumatic brain injury outcome: a double-blind, randomized, controlled, clinical trial
    Fattahi, Arash
    Taheri, Morteza
    BRAIN INJURY, 2019, 33 (03) : 399 - 400
  • [32] Traditional Vietnamese medicine Kovir capsule in patients with mild COVID-19: A double-blind randomized controlled trial
    Huynh Nguyen Loc
    Truong Thi Ngoc Lan
    Dinh Thi Lan Huong
    Nguyen Thanh Tuyen
    Tran Minh Quang
    Ly Minh Dao
    Pham Hung Van
    Nguyen Lam Vuong
    PHYTOTHERAPY RESEARCH, 2022, 36 (07) : 2878 - 2888
  • [33] Nitazoxanide in Patients Hospitalized With COVID-19 Pneumonia: A Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial
    Rocco, Patricia R. M.
    Silva, Pedro L.
    Cruz, Fernanda F.
    Tierno, Paulo F. G. M. M.
    Rabello, Eucir
    Junior, Jefiton Cordeiro
    Haag, Firmino
    de avila, Renata E.
    da Silva, Joana D. G.
    Mamede, Mariana M. S.
    Buchele, Konrad S.
    Barbosa, Luiz C. V.
    Cabral, Anna C.
    Junqueira, Antonio A. F.
    Araujo-Filho, Joao A.
    da Costa, Lucianna A. T. J.
    Alvarenga, Pedro P. M.
    Moura, Alexandre S.
    Carajeleascow, Ricardo
    de Oliveira, Mirella C.
    Silva, Roberta G. F.
    Soares, Cynthia R. P.
    Fernandes, Ana Paula S. M.
    Fonseca, Flavio Guimaraes
    Camargos, Vidyleison Neves
    Reis, Julia de Souza
    Franchini, Kleber G.
    Luiz, Ronir R.
    Morais, Sirlei
    Sverdloff, Carlos
    Martins, Camila Marinelli
    Felix, Nathane S.
    Mattos-Silva, Paula
    Nogueira, Caroline M. B.
    Caldeira, Dayene A. F.
    Pelosi, Paolo
    Lapa-e-Silva, Jose R.
    FRONTIERS IN MEDICINE, 2022, 9
  • [34] Bufei huoxue capsules in the management of convalescent COVID-19 infection: study protocol for a multicenter, double-blind, and randomized controlled trial
    Chen, Yuqin
    He, Wenjun
    Lu, Wenju
    Xing, Yue
    Bai, Jianling
    Yu, Hao
    Zhou, Jiawei
    Liang, Jingyi
    Chen, Jiyuan
    Hou, Chi
    Zhong, Bihua
    Wang, Ting
    Feng, Huazhuo
    Chen, Xu
    Wang, Tao
    Yang, Kai
    Zhang, Nuofu
    Zhong, Nanshan
    Liu, Chunli
    Wang, Jian
    PULMONARY CIRCULATION, 2021, 11 (03)
  • [35] Possible therapeutic effects of boron citrate and oleoylethanolamide supplementation in patients with COVID-19: A pilot randomized, double-blind, clinical trial
    Akbari, Neda
    Ostadrahimi, Alireza
    Tutunchi, Helda
    Pourmoradian, Samira
    Farrin, Nazila
    Najafipour, Farzad
    Soleimanzadeh, Hamid
    Kafil, Behnam
    Mobasseri, Majid
    JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, 2022, 71
  • [36] Efficacy and safety of Levamisole treatment in clinical presentations of non-hospitalized patients with COVID-19: a double-blind, randomized, controlled trial
    Firozabad, Amirreza Roostaei
    Meybodi, Zohreh Akhoundi
    Mousavinasab, Seyed Ruhollah
    Sahebnasagh, Adeleh
    Jelodar, Mohsen Gholinataj
    Karimzadeh, Iman
    Habtemariam, Solomon
    Saghafi, Fatemeh
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [37] Efficacy and safety of Levamisole treatment in clinical presentations of non-hospitalized patients with COVID-19: a double-blind, randomized, controlled trial
    Amirreza Roostaei Firozabad
    Zohreh Akhoundi Meybodi
    Seyed Ruhollah Mousavinasab
    Adeleh Sahebnasagh
    Mohsen Gholinataj Jelodar
    Iman Karimzadeh
    Solomon Habtemariam
    Fatemeh Saghafi
    BMC Infectious Diseases, 21
  • [38] Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Crippa, Jose Alexandre S.
    Pacheco, Julia Cozar
    Zuardi, Antonio W.
    Guimaraes, Francisco S.
    Campos, Alline Cristina
    Lima Osorio, Flavia de
    Loureiro, Sonia Regina
    dos Santos, Rafael G.
    Souza, Jose Diogo S.
    Ushirohira, Juliana Mayumi
    Ferreira, Rafael Rinaldi
    Mancini Costa, Karla Cristinne
    Scomparin, Davi Silveira
    Scarante, Franciele Franco
    Pires-Dos-Santos, Isabela
    Mechoulam, Raphael
    Kapczinski, Flavio
    Fonseca, Benedito A. L.
    Esposito, Danillo L. A.
    Costa Passos, Afonso Dinis
    Dal Fabbro, Amaury Lelis
    Bellissimo-Rodrigues, Fernando
    Arruda, Eurico
    Scarpelini, Sandro
    Andraus, Maristela Haddad
    Nather Junior, Julio Cesar
    Wada, Danilo Tadao
    Koenigkam-Santos, Marcel
    Santos, Antonio Carlos
    Busatto Filho, Geraldo
    Hallak, Jaime E. C.
    CANNABIS AND CANNABINOID RESEARCH, 2022, 7 (05) : 658 - 669
  • [39] Efficacy of Nanocurcumin as an Add-On Treatment for Patients Hospitalized with COVID-19: A Double-Blind, Randomized Clinical Trial
    Ahmadi, Sedigheh
    Mehrabi, Zeinab
    Zare, Morteza
    Ghadir, Sara
    Masoumi, Seyed Jalil
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2023, 2023
  • [40] Evaluation of the effect of sofosbuvir and daclatasvir in hospitalized COVID-19 patients: a randomized double-blind clinical trial (DISCOVER)
    Mobarak, Sara
    Salasi, Mehdi
    Hormati, Ahmad
    Khodadadi, Javad
    Ziaee, Masood
    Abedi, Farshid
    Ebrahimzadeh, Azadeh
    Azarkar, Zohreh
    Mansour-Ghanaei, Fariborz
    Joukar, Farahnaz
    Yeganeh, Sara
    Yaghubi Kalurazi, Tofigh
    Naghipour, Mohammadreza
    Mehrabi, Zeinab
    Bahadori, Amir Reza
    Yaghoubi, Shoeleh
    Moslemi, Rohollah
    Abbaspour Kasgari, Hamideh
    Fakheri, Hafez
    Moghimi, Minoo
    Shabani, Amir Mohammad
    Nekoukar, Zahra
    Babamahmoodi, Farhang
    Davoudi Badabi, Ali Reza
    Davoodi, Lotfollah
    Hassaniazad, Mehdi
    Barahimi, Elham
    Tousi, Abdolali
    Sadeghi, Anahita
    Hosamirudsari, Hadiseh
    Ali Asgari, Ali
    Abdollahi, Mohammad
    Anushiravani, Amir
    Shabani, Minoosh
    Shokouhi, Shervin
    Khajavirad, Nasim
    Salehi, Mohammadreza
    Dehghan Manshadi, Seyed Ali
    Mousavi, Hashem
    Zolfaghari, Farnaz
    Azimi, Elmira
    Zeinali, Aida
    Akbarpour, Elham
    Merat, Dorsa
    Eslami, Gholamali
    Mousaviasl, Sajedeh
    Sayar, Sara
    Radmanesh, Esmat
    Ebrahimzadeh, Mona
    Arizavi, Zahra
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (03) : 758 - 766
12345